1. Home
  2. BRW vs OSUR Comparison

BRW vs OSUR Comparison

Compare BRW & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BRW

Saba Capital Income & Opportunities Fund SBI

HOLD

Current Price

$7.04

Market Cap

308.8M

Sector

Finance

ML Signal

HOLD

Logo OraSure Technologies Inc.

OSUR

OraSure Technologies Inc.

HOLD

Current Price

$2.49

Market Cap

174.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRW
OSUR
Founded
1987
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
308.8M
174.3M
IPO Year
N/A
1986

Fundamental Metrics

Financial Performance
Metric
BRW
OSUR
Price
$7.04
$2.49
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
$3.00
AVG Volume (30 Days)
222.1K
668.1K
Earning Date
01-01-0001
02-24-2026
Dividend Yield
15.59%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$125,703,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$3.70
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.15
$2.08
52 Week High
$8.30
$4.22

Technical Indicators

Market Signals
Indicator
BRW
OSUR
Relative Strength Index (RSI) 45.52 51.87
Support Level $6.95 $2.33
Resistance Level $7.04 $2.50
Average True Range (ATR) 0.07 0.09
MACD 0.01 0.01
Stochastic Oscillator 66.65 76.92

Price Performance

Historical Comparison
BRW
OSUR

About BRW Saba Capital Income & Opportunities Fund SBI

Saba Capital Income & Opportunities Fund is a diversified, closed-end management investment company. It seeks to provide investors with a high level of current income, with a secondary goal of capital appreciation. It invests globally in debt and equity securities of public and private companies, which includes, investing in closed-end funds, public and private debt instruments, and other securities.

About OSUR OraSure Technologies Inc.

OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.

Share on Social Networks: